Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • Log out
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • Log out
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds
Meeting ReportOncology: Clinical Therapy & Diagnosis (includes Phase 2, Phase 3, post approval studies) - GU

Prognostic Significance of Negative PSMA PET/CT in Biochemical Recurrence of Prostate Cancer: Insights from a Clinical Trial Subgroup Analysis

Sara Harsini, Patrick Martineau, Sonia Plaha, Heather Saprunoff, Catherine Chen, Julia Bishop, Scott Tyldesley, Don Wilson and Francois Benard
Journal of Nuclear Medicine June 2024, 65 (supplement 2) 241500;
Sara Harsini
1BC Cancer
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Patrick Martineau
1BC Cancer
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Sonia Plaha
2BC Cancer, Canada
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Heather Saprunoff
1BC Cancer
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Catherine Chen
3Department of Molecular Oncology, BC Cancer Research Institute, BC, Canada
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Julia Bishop
1BC Cancer
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Scott Tyldesley
1BC Cancer
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Don Wilson
1BC Cancer
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Francois Benard
4BC Cancer Research Institute
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
Loading

Article Figures & Data

Figures

  • Figure
    • Download figure
    • Open in new tab
    • Download powerpoint
  • Figure
    • Download figure
    • Open in new tab
    • Download powerpoint
Previous
Back to top

In this issue

Journal of Nuclear Medicine
Vol. 65, Issue supplement 2
June 1, 2024
  • Table of Contents
  • Index by author
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Prognostic Significance of Negative PSMA PET/CT in Biochemical Recurrence of Prostate Cancer: Insights from a Clinical Trial Subgroup Analysis
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
Prognostic Significance of Negative PSMA PET/CT in Biochemical Recurrence of Prostate Cancer: Insights from a Clinical Trial Subgroup Analysis
Sara Harsini, Patrick Martineau, Sonia Plaha, Heather Saprunoff, Catherine Chen, Julia Bishop, Scott Tyldesley, Don Wilson, Francois Benard
Journal of Nuclear Medicine Jun 2024, 65 (supplement 2) 241500;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Prognostic Significance of Negative PSMA PET/CT in Biochemical Recurrence of Prostate Cancer: Insights from a Clinical Trial Subgroup Analysis
Sara Harsini, Patrick Martineau, Sonia Plaha, Heather Saprunoff, Catherine Chen, Julia Bishop, Scott Tyldesley, Don Wilson, Francois Benard
Journal of Nuclear Medicine Jun 2024, 65 (supplement 2) 241500;
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
  • Figures & Data
  • Info & Metrics

Related Articles

  • No related articles found.
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

  • Comparison of Post-Therapy 4 and 24-hour 177Lu-PSMA SPECT/CT and Pre-Therapy PSMA PET/CT in Assessment of Disease in Men with Metastatic Castrate-Resistant Prostate Cancer
  • Clinical relevance of post-therapy SPECT/CT in prostate cancer patients treated with Lutetium Lu 177 vipivotide tetraxetan
  • Clinical Phenotype and Outcomes of mCRPC Patients Resistant to 225Ac-PSMA Radioligand Therapy: Analysis of the WARMTH Act Multinational Study
Show more Oncology: Clinical Therapy & Diagnosis (includes Phase 2, Phase 3, post approval studies) - GU

Similar Articles

SNMMI

© 2025 SNMMI

Powered by HighWire